SCHEMBL10736788

SCHEMBL10736788

O=C(Cn1cc(I)cnc1=O)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.48
POLB P06746 1/20 0.48
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
TP53 P04637 2/20 0.43
GRIN2B Q13224 1/20 0.43
EGFR P00533 1/20 0.42
HTT P42858 1/20 0.41
MGAM O43451 1/20 0.41
AMY1A P0DUB6 1/20 0.41
GAA P10253 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
MKNK1 Q9BUB5 1/20 0.41
MKNK2 Q9HBH9 1/20 0.41
GSK3A P49840 1/20 0.41
GSK3B P49841 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10732555 0.82 GRIN2B (0.48) SMN1; SMN2POLBMEN1KMT2ARAB9A
SCHEMBL10733734 0.82 SMN1; SMN2 (0.48) SMN1; SMN2POLBMEN1KMT2ARAB9A
SCHEMBL10733533 0.82 POLB (0.55) SMN1; SMN2POLBMEN1KMT2ARAB9A
SCHEMBL10801047 0.81 TRPA1 (0.38) SMN1; SMN2POLBGRIN2B
SCHEMBL31055021 0.74 SRC (0.45) SMN1; SMN2POLBMEN1KMT2ARAB9A
SCHEMBL10738872 0.72 HSD17B10 (0.47) SMN1; SMN2POLBMEN1KMT2ARAB9A
SCHEMBL10739317 0.72 KMT2A (0.49) POLBMEN1KMT2ARAB9ANPC1
SCHEMBL10738569 0.72 KMT2A (0.51) SMN1; SMN2POLBMEN1KMT2ARAB9A
SCHEMBL10740587 0.69 RAB9A (0.48) SMN1; SMN2POLBKMT2ARAB9ANPC1
SCHEMBL10733675 0.69 PKM (0.49) SMN1; SMN2MEN1KMT2ARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4636509-A Substituted pyrimidin-2-ones, the salts thereof, processes for their preparation, pharmaceutical compositions containing them and a method therefor GLAXO GROUP LIMITED (GB) 1987-01-13 US disclosed